An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
As required under the Grants Oversight and New Efficiency (GONE) Act of 2016, Public Law 114-117, we conducted a risk assessment of FEMA’s grant closeout process to determine whether a full audit is warranted in the future. We identified risks in three overarching areas: Unreliable Systems of Record, Lack of Integration in Grant Closeout Policies and Guidance, and Delays in Grant Closeout and Deobligation of Funds. As a result, we may conduct a full audit of FEMA’s grant closeout process at a future date. DHS and FEMA concurred with our risk assessment results. We made no recommendations to FEMA.
Financial Audit of USAID Resources Managed by ONG Decentralisation-Droits Humains-Developpement Local (ONG 3D) in Senegal Under Multiple Awards, January 1 to December 31, 2018
Independent Audit Report on the Louis Berger Group, Inc.'s Costs Incurred and Billed to DPK Consulting (dba Tetra Tech DPK) in Iraq, Subcontract 267-C-10-00006-00, April 1, 2013, September 30, 2015
Audit of USAID Resources Managed by Eco-Consult Under the Hydroponic Green Farming Initiative in Jordan, Cooperative Agreement AID-263-A-13-00004, October 1, 2013 Through June 30, 2017
Closeout Audit of the Cost Representation Statement of AECOM International Development, Inc., Palestinian Energy Project in West Bank and Gaza, Task order AID-294-TO-16-00006, January 1, 2018 to January 31, 2019
Closeout Examination of Technical Group for General Contracting Company's Compliance With Terms and Conditions of Subcontract 24043-16-NW-SA002, Local Government and Infrastructure Program in West Bank and Gaza, March 29 to August 29, 2016
Adequate access to treatment is vital in addressing the escalating rates of addiction and mortality related to opioid misuse and abuse. Medication-assisted treatment (MAT) couples medication (such as buprenorphine, methadone, or naltrexone) with counseling and behavioral therapies to treat opioid use disorder. Since 2000, Congress has enacted several measures to increase the availability of MAT, including the creation and expansion of the Buprenorphine Waiver Program (waiver program). The waiver program allows physicians and certain other qualified providers to prescribe buprenorphine to patients in office settings rather than limiting this service to specialized opioid treatment programs. Despite these efforts, studies still show that only a small percentage of Americans who need treatment actually receive it.
